Beneficiaries of negotiated reimbursement drugs
RecordSTO-R7VPZ3Y198-V455WDHSD3-E3W11N
China · January 2018 – October 2024
Beneficiaries of negotiated reimbursement drugs in China were 830 million in January 2018 – October 2024 (State Council).
Beneficiaries of negotiated reimbursement drugs: every country and year, and how it is measured
- Publisher
- State Council
- Authority tier
- T1 Official
- Locator
- 7年累计将835种药品新增进入目录
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
截至2024年10月底，医保基金为协议期内谈判药品支付累计超过3500亿元，惠及患者8.3亿人次。
Checked: the figure 830 millionis stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
State Council of China. (2024). 2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网. Retrieved September 17, 2026, from https://www.gov.cn/zhengce/202411/content_6989980.htm. Via StatOrigin, https://statorigin.org/stat/stat_R7VPZ3Y198V455WDHSD3E3W11N
Other formats: MLA, Chicago, BibTeX
- MLA
- State Council of China. "2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网." 2024, https://www.gov.cn/zhengce/202411/content_6989980.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_R7VPZ3Y198V455WDHSD3E3W11N.
- Chicago
- State Council of China. "2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网." 2024. https://www.gov.cn/zhengce/202411/content_6989980.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_R7VPZ3Y198V455WDHSD3E3W11N.
- BibTeX
- @misc{statecouncil2024beneficiariese3w11n, author = {{State Council of China}}, title = {2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药\_政策解读\_中国政府网}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_R7VPZ3Y198V455WDHSD3E3W11N}, note = {Original source: https://www.gov.cn/zhengce/202411/content\_6989980.htm. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网
- Type
- Press release
- Published
- —
- Locator
- 7年累计将835种药品新增进入目录
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 26 September 2026
- Permanent URL
- /stat/stat_R7VPZ3Y198V455WDHSD3E3W11N